210 articles
Ludolph Brauer
Ludolph Brauer (1865–1951) was a German internist who founded collapse therapy for tuberculosis, developed positive-pressure ventilation for open-chest surgery, and directed the Eppendorf hospital in Hamburg from 1910 to 1934.
Lynn M. Taussig
Lynn M. Taussig (1942–2025) was an American pediatric pulmonologist who founded the Tucson Children's Respiratory Study, a landmark asthma birth cohort, and was the first physician President and CEO of National Jewish Health.
Marc Decramer
Marc Decramer (1953–2026) was a Belgian pulmonologist and professor at KU Leuven who led the 2008 four-year tiotropium trial in COPD, chaired the GOLD initiative, and served as CEO of UZ Leuven.
Marc Humbert
Marc Humbert (born 1963) is a French physician-scientist known for transforming the treatment of pulmonary arterial hypertension, and Dean of the Université Paris-Saclay Faculty of Medicine.
Marc Peters‐Golden
Marc Peters-Golden is an American pulmonary physician-scientist who spent over four decades at the University of Michigan studying eicosanoids in lung inflammation, and received the American Thoracic Society's 2026 J. Burns Amberson Lecture.
Marcus Mall
Marcus Mall, or Marcus A. Mall, born 1968 in Stuttgart, is a German pediatric pulmonologist known for cystic fibrosis research who directs pediatric respiratory medicine at Charité Berlin.
Marius M. Hoeper
Marius M. Hoeper is a German pulmonologist, director of respiratory medicine at Hannover Medical School, who helped develop most drugs approved for pulmonary arterial hypertension.
Mark T. Dransfield
Mark T. Dransfield, also cited as Mark Dransfield, is an American pulmonologist at the University of Alabama at Birmingham, chair of its Department of Medicine since 2025, known for COPD exacerbation research.
Mark T. Gladwin
Mark T. Gladwin, also known as Mark Gladwin, is an American physician-scientist and the 31st Dean of the University of Maryland School of Medicine since 2022.
Marlene Rabinovitch
Marlene Rabinovitch is a Canadian-trained American physician-scientist, the Dwight and Vera Dunlevie Professor of Pediatric Cardiology at Stanford since 2002, known for pulmonary hypertension research.
Marlies Wijsenbeek
Marlies Wijsenbeek (Marlies S. Wijsenbeek-Lourens) is a Dutch pulmonologist and professor of interstitial lung diseases at Erasmus MC in Rotterdam, known for the 2025 PREDMETH and FIBRONEER-IPF trials.
Martin J. Tobin
Martin J. Tobin is an Irish-born pulmonary and critical care physician at Loyola University Chicago and Hines VA Hospital, known for the rapid shallow breathing index.
Maurice S. Segal
Maurice S. Segal was an American physician and pulmonary researcher in Boston who pioneered inhalational aerosol drug therapy for bronchial asthma at Boston City Hospital and Tufts.
MeiLan K. Han
MeiLan K. Han is an American pulmonologist and clinical researcher who is Chief of Pulmonary and Critical Care at the University of Michigan, known for COPD research.
Michael A. Matthay
Michael A. Matthay is an American pulmonary and critical care physician-researcher at UCSF since 1979, known for lung injury research and leading national ARDS clinical trials, including the landmark lower-tidal-volume ventilation trial.
Michael E. Wechsler
Michael E. Wechsler is an American pulmonologist who directs the Cohen Family Asthma Institute and researches severe asthma and EGPA at National Jewish Health in Denver.
Michael J. Holtzman
Michael J. Holtzman is an American physician-scientist in pulmonary immunology at Washington University in St. Louis, who led its pulmonary division from 1992 to 2022.
Michael J. Welsh
Michael J. Welsh is an American physician-scientist at the University of Iowa who showed the CFTR protein is a chloride channel, enabling CFTR-modulator drugs for cystic fibrosis.
Michael K. Gould
Michael K. Gould is an American pulmonologist and health services researcher at Kaiser Permanente in California, known for his 2014 New England Journal of Medicine review of low-dose CT lung-cancer screening.
Michael T. Newhouse
Michael T. Newhouse (1935–2023) was a Canadian respirologist at McMaster University in Hamilton, Ontario, known for developing the AeroChamber inhaler spacer and founding the Firestone Institute for Respiratory Health.
Michel Aubier
Michel Aubier, born 1947, is a French pulmonologist and member of the Académie nationale de médecine known for research on severe asthma, COPD, and air pollution.
Miles Weinberger
Miles M. Weinberger was an American pediatric allergist and pulmonologist at the University of Iowa whose theophylline dosing research made it the standard childhood asthma treatment.
Najib M. Rahman
Najib M. Rahman is a British respiratory physician and Professor of Respiratory Medicine at Oxford, director of its trials unit, known for the MIST2 and RAMPP pleural disease trials.
Nicholas W. Morrell
Nicholas W. Morrell is a British physician-scientist in pulmonary vascular medicine and Emeritus Professor of Medicine at Cambridge, known for defining how BMPR-II mutations cause pulmonary arterial hypertension.
Noel G. McElvaney
Noel G. McElvaney (Noel Gerry McElvaney) is an Irish respiratory physician-scientist, Professor of Medicine at RCSI since 1998, known for cystic fibrosis and alpha-1 antitrypsin deficiency research.
Norbert F. Voelkel
Norbert F. Voelkel is a German-trained physician-scientist in pulmonary vascular medicine, trained at Hamburg and Denver, known for work on pulmonary hypertension, emphysema, and the right ventricle.
Olivier Sitbon
Olivier Sitbon (born 1961) is a French professor of respiratory medicine at Hôpital Bicêtre known for clinical trials in pulmonary arterial hypertension, including the 2015 GRIPHON trial.
Pamela B. Davis
Pamela B. Davis is an American pulmonary physician-scientist at Case Western Reserve University whose 1995 trial established high-dose ibuprofen as a treatment slowing cystic fibrosis lung decline.
Pascal Chanez
Pascal Chanez is a French physician-scientist in respiratory medicine and allergology, professor at Marseille and head of its severe asthma clinic, co-author of the mepolizumab trials DREAM and MENSA.
Paul M. O’Byrne
Paul M. O'Byrne is an Irish-born Canadian physician-scientist at McMaster University whose research established airway inflammation as central to asthma, and who led the SYGMA trials changing mild asthma treatment.